To the best of our knowledge, no other study has measured IL-23 and IL-17 levels in critically ill COVID-19 patients, or compared their levels to critically ill non-COVID-19 patients and non-critically ill COVID-19 patients. This evidence concerns the gene IL17A and COVID-19.